Brief: Respirerx Pharmaceuticals updates on ops, liquidity situation
25/08/2017 15:55
Aug 25 (Reuters) - RespireRx Pharmaceuticals Inc RSPI.PK
* RespireRx Pharmaceuticals Inc files June 30, 2017
quarterly report on Form 10-Q and provides update
* RespireRx Pharmaceuticals - If co is unable to access
sufficient cash resources, it may be forced to discontinue its
operations entirely and liquidate
Source text for Eikon: ID:nMKWSkHrSa
Further company coverage: RSPI.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Respirerx Pharmaceuticals
See all newsBrief: Respirerx Pharmaceuticals Announces That CFO Jeff Margolis Is Presenting At The Investor Summit
NZ's EROAD eyes best day in over 3 weeks on clearance for Cortex acquisition
Brief: Respirerx Pharma Says Sent Formal Notice To Board Of Therapix Biosciences
Brief: Respirerx Pharmaceuticals updates on ops, liquidity situation